Oxford BioMedica

1 Follower

About

Official Twitter for Oxford Biomedica (LSE: OXB). We're developing & manufacturing innovative gene-based medicines in ophthalmology, CNS & cancer.

Nick Page
Chief Operations Officer
Dmitry Zamoryakhin
Chief Medical Officer
Helen Stephenson-Ellis
Chief People Officer
James Miskin
Chief Technical Officer
Jason Slingsby
Chief Business Officer
Kyriacos Mitrophanous
Chief Scientific Officer
Natalie Walter
General Counsel
Stuart Paynter
Chief Financial Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.